These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 24878819)
1. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer. Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819 [TBL] [Abstract][Full Text] [Related]
2. Involvement of nuclear NHERF1 in colorectal cancer progression. Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563 [TBL] [Abstract][Full Text] [Related]
3. NHERF1: molecular brake on the PI3K pathway in breast cancer. Georgescu MM Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260 [TBL] [Abstract][Full Text] [Related]
4. Biological role of NHERF1 protein expression in breast cancer. Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling. Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance. Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899 [TBL] [Abstract][Full Text] [Related]
10. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111 [TBL] [Abstract][Full Text] [Related]
11. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients. Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918 [TBL] [Abstract][Full Text] [Related]
12. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells. Bellizzi A; Greco MR; Rubino R; Paradiso A; Forciniti S; Zeeberg K; Cardone RA; Reshkin SJ Int J Oncol; 2015 Mar; 46(3):1214-24. PubMed ID: 25530180 [TBL] [Abstract][Full Text] [Related]
13. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS. Sun J; Li P; Yang J Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004 [TBL] [Abstract][Full Text] [Related]
14. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling. DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012 [TBL] [Abstract][Full Text] [Related]
15. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191 [TBL] [Abstract][Full Text] [Related]
16. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Pan Y; Weinman EJ; Dai JL Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691 [TBL] [Abstract][Full Text] [Related]
17. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733 [TBL] [Abstract][Full Text] [Related]
19. Role of Na+/H+ exchanger regulatory factor 1 in forward trafficking of the type IIa Na+-Pi cotransporter. Ketchem CJ; Khundmiri SJ; Gaweda AE; Murray R; Clark BJ; Weinman EJ; Lederer ED Am J Physiol Renal Physiol; 2015 Jul; 309(2):F109-19. PubMed ID: 25995109 [TBL] [Abstract][Full Text] [Related]
20. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease. Wang JQ; Qin F; Zhu L J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]